MGX compared with CATO: revenue, margins and what each company keeps, and the suppliers and customers both name

MGXMetagenomi Therapeutics, Inc.

Mkt capRevenueRevenue

CATOCato Corp

Mkt capRevenueRevenue

Compare

MGXMetagenomi Therapeutics, Inc.

CATOCato Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only MGX 2

IONSIonis Pharmaceuticalscustomer

—Acuitas Therapeuticsunlistedsupplier

Shared 0

No disclosed counterparties: CATO.

Only CATO 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

MGXMetagenomi Therapeutics, Inc.

0.73· pre 0.73· delayed

Mkt cap$29.8MRevenue$1MQ1 FY26Revenue$25MFY25

CATOCato Corp

2.30· pre 2.30· delayed

Pre-marketNov 5 '26delayed

Mkt cap$45.8MRevenue$166MQ2 FY26Revenue$654MFY25

Compare

Pre-marketNov 5 '26delayed

MGXMetagenomi Therapeutics, Inc.

CATOCato Corp

0.73pre 0.73delayed

Price

2.30pre 2.30delayed

$29.8M

Mkt cap

$45.8M

Q1 FY26$1M

Revenue

$166MQ2 FY26

FY25$25M

Revenue

$654MFY25

MGX0.73vsCATO2.30Pre-marketNov 5 '26delayed